---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-001203"
form_type: "8-K"
ticker: "ELDN"
cik: "0001404281"
company_name: "Eledon Pharmaceuticals, Inc."
filed_at: "2022-01-13T23:59:59+00:00"
generated_at: "2026-06-27T18:11:28.700623+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Eledon exchanges 550K common for Series X1 preferred; convertible at 55.56 per share

## Summary
- Exchanged 550,000 common shares for 9,899.99 Series X1 preferred shares with BVF entities.
- Series X1 preferred convertible into ~6.55M shares at 55.5556 common per preferred (post-reverse split).
- After exchange, common outstanding: 13,756,788; Series X1 preferred outstanding: ~117,970 shares.
- Exchange exempt under Section 3(a)(9) of Securities Act; no registration required.

## SEC filing metadata
- accession: 0001564590-22-001203
- form_type: 8-K
- ticker: ELDN
- cik: 0001404281
- company_name: Eledon Pharmaceuticals, Inc.
- filed_at: 2022-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404281/000156459022001203/0001564590-22-001203-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404281/000156459022001203/eldn-8k_20220111.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-001203
- JSON: https://secwatch.observer/filing/0001564590-22-001203.json
- Plain text: https://secwatch.observer/filing/0001564590-22-001203.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.